A small pilot study indicates that following up an imperfectly matched organ transplant with an infusion of the donor's stem cells may free recipients from a lifetime of anti-rejection drugs.

A small pilot study indicates that following up an imperfectly matched organ transplant with an infusion of the donor's stem cells may free recipients from a lifetime of anti-rejection drugs.